We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

28 hedge funds and large institutions have $12.5M invested in Protara Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

12% more funds holding

Funds holding: 25 → 28 (+3)

0.03% more ownership

Funds ownership: 1.06% → 1.09% (+0.03%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

5% less capital invested

Capital invested by funds: $13.2M → $12.5M (-$658K)

Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.7%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
7
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$135K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$87K
3
ARTA
A.R.T. Advisors
New York
+$79.8K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$55.2K
5
BlackRock
BlackRock
New York
+$49.2K

Top Sellers

1
BBA
Baker Bros. Advisors
New York
-$170K
2
PPCM
Pillar Pacific Capital Management
California
-$21K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$6.13K
4
UBS Group
UBS Group
Switzerland
-$5.01K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$3.43M – – –
DM
2
Deerfield Management
New York
$2.33M – – –
PI
3
Pharmstandard International
Luxembourg
$2.04M – – –
MAM
4
MPM Asset Management
Massachusetts
$1.72M – – –
PA
5
Perceptive Advisors
New York
$585K – – –
DVC
6
Deer VII & Co
New York
$551K – – –
BBA
7
Baker Bros. Advisors
New York
$523K -$170K -2,270 -23%
Vanguard Group
8
Vanguard Group
Pennsylvania
$416K +$87K +1,164 +24%
Jacobs Levy Equity Management
9
Jacobs Levy Equity Management
New Jersey
$126K +$135K +1,807 New
BCM
10
Bridgeway Capital Management
Texas
$103K – – –
Renaissance Technologies
11
Renaissance Technologies
New York
$92K +$41.1K +550 +72%
FCI
12
Financial Counselors Inc
Kansas
$88K – – –
WS
13
Wedbush Securities
California
$75K +$48.1K +643 +151%
ARTA
14
A.R.T. Advisors
New York
$74K +$79.8K +1,068 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$66K +$897 +12 +1%
VKH
16
Virtu KCG Holdings
New York
$64K +$9.42K +126 +16%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$52K +$55.2K +739 New
BlackRock
18
BlackRock
New York
$45K +$49.2K +659 New
KCM
19
Kornitzer Capital Management
Kansas
$34K +$13.8K +185 +62%
Northern Trust
20
Northern Trust
Illinois
$25K +$1.05K +14 +4%
Citadel Advisors
21
Citadel Advisors
Florida
$22K +$23.3K +312 New
Mariner
22
Mariner
Kansas
$19K – – –
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$15K -$6.13K -82 -27%
Acadian Asset Management
24
Acadian Asset Management
Massachusetts
$15K +$15.8K +212 New
TRCT
25
Tower Research Capital (TRC)
New York
$12K +$9.71K +130 +351%
1
2

TARA Hedge Fund Activity: Q1 2017 in Review

28 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q1 2017, worth a combined $12.5M — down 5% from $13.2M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TARA positions and 1 closed out — a net gain of 6 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $135K. The largest seller was Baker Bros. Advisors, cutting an estimated $170K.

  • 28 institutional investors held Protara Therapeutics (TARA) as of Q1 2017, up from 25 in Q4 2016.
  • Funds reported $12.5M of Protara Therapeutics stock for Q1 2017, down 5% quarter-over-quarter.
  • 7 funds opened new Protara Therapeutics positions in Q1 2017 and 1 closed out, a net change of +6 holders.
  • The largest Protara Therapeutics buyer in Q1 2017 was Jacobs Levy Equity Management, an estimated $135K added.
  • The largest Protara Therapeutics seller in Q1 2017 was Baker Bros. Advisors, an estimated $170K sold.

Based on aggregated 13F filings for Q1 2017.